dc.contributor.author | GENICA Network | |
dc.contributor.author | kConFaB | |
dc.contributor.author | AOCS Study Group | |
dc.contributor.author | SWE-BRCA | |
dc.contributor.author | HEBON | |
dc.contributor.author | EMBRACE | |
dc.date.accessioned | 2014-09-18T08:44:01Z | |
dc.date.available | 2014-09-18T08:44:01Z | |
dc.date.issued | 2012-06-29 | |
dc.identifier | 19907341 | |
dc.identifier | b7883904-a324-4a6e-b695-bc509aafe508 | |
dc.identifier | 22768030 | |
dc.identifier | 84863215020 | |
dc.identifier.citation | GENICA Network , kConFaB , AOCS Study Group , SWE-BRCA , HEBON & EMBRACE 2012 , ' Breast cancer risk and 6q22.33 : combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 ' , PloS ONE , vol. 7 , no. 6 , e35706 . https://doi.org/10.1371/journal.pone.0035706 | en |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | http://hdl.handle.net/2164/3503 | |
dc.format.extent | 10 | |
dc.format.extent | 335966 | |
dc.language.iso | eng | |
dc.relation.ispartof | PloS ONE | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject.lcc | RC0254 | en |
dc.title | Breast cancer risk and 6q22.33 : combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1371/journal.pone.0035706 | |